Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AD 337 for fibromyalgia in female subjects
2005-005194-30Phase 2Completed
- Sponsor
- Arakis
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in fibromyalgia (FM) comparing AD 337 with Placebo (2 arms). Primary endpoint: Fibromyalgia Impact Questionnaire total score at 4 weeks. Started Mar 2006; status: completed.
02
Drugs
AD 337
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on 2005-005194-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005194-30.